SCHEMBL3467248

SCHEMBL3467248

N#Cc1cccc(-c2ccc(CCC(CCCc3ccc(S(=O)(=O)Nc4ccccc4)cc3)C(=O)O)cc2)c1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 2/20 0.51
ADAMTS4 O75173 2/20 0.51
MMP12 P39900 1/20 0.51
P4HB P07237 1/20 0.46
GPR27 Q9NS67 2/20 0.45
AVPR2 P30518 1/20 0.45
KAT6A Q92794 2/20 0.44
ACLY P53396 3/20 0.43
CNR1 P21554 1/20 0.42
CNR2 P34972 1/20 0.42
MMP2 P08253 1/20 0.42
MMP3 P08254 1/20 0.42
HDAC1 Q13547 2/20 0.41
HDAC8 Q9BY41 1/20 0.41
PTGES2 Q9H7Z7 1/20 0.41
PGR P06401 1/20 0.41
ATIC P31939 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3467103 0.88 MMP13 (0.46) MMP13ADAMTS4MMP12ACLYCNR1
SCHEMBL7928277 0.87 MMP12 (0.64) MMP13ADAMTS4MMP12MMP2MMP3
SCHEMBL7932591 0.86 MMP12 (0.63) MMP13ADAMTS4MMP12MMP2MMP3
SCHEMBL1860527 0.83 HDAC1 (0.54) MMP2MMP3HDAC1HDAC8
SCHEMBL3467249 0.79 MMP12 (0.54) MMP13ADAMTS4MMP12MMP2MMP3
SCHEMBL1858150 0.79 LIMK2 (0.54) HDAC1HDAC8
SCHEMBL7917889 0.78 MMP12 (0.55) MMP13ADAMTS4MMP12MMP2MMP3
SCHEMBL3466770 0.78 MMP13 (0.45) MMP13ADAMTS4MMP12CNR1CNR2
SCHEMBL8039484 0.78 HTR6 (0.58) MMP2MMP3HDAC1HDAC8
SCHEMBL7924636 0.78 MMP12 (0.65) MMP13ADAMTS4MMP12MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO claimed
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO disclosed